| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Fibroblast Cells: Changes in Benzo(a)pyrene Metabolism and Phorbol Ester Binding1
Institute of Human Nutrition [M. S. M.], Cancer Center/Institute of Cancer Research [M. S. M., A. M. J.], and Department of Pharmacology [A. M. J.], Columbia University, New York, New York 10032
The mouse embryo fibroblast cell line, C3H 10T
C18, was studied as an in vitro experimental model to investigate the mechanism and specificity behind the modulation of carcinogenesis by dietary lipid. The cells were grown in medium supplemented with 95 µM stearate, linoleate, or palmitate as fatty acid/albumin complexes, during which time they maintained normal growth and morphology characteristics. After 5 days of supplementation total cellular lipid fatty acid was enriched in the supplemented fatty acid. By Day 40, however, fatty acid profiles of all groups were the same. Cellular uptake and utilization of 14C-radiolabeled fatty acids were measured. Within 24 h of supplementation, label was incorporated into cholesterol and diglycerides, cholesterol ester, alkyldi-acylglycerols, and phospholipids. Approximately half of the radiolabel was found in phosphatidylcholine. Supplementation significantly increased the rate of benzo(a)pyrene metabolism, but did not affect DNA modification by benzo(a)pyrene. Phorbol dibutyrate binding to C3H 10T
cells at 4°C was modified by lipid supplementation. At 37°C and 23°C, phorbol dibutyrate binding was characterized by both high- and low-affinity sites for linoleate- and stearate-supplemented cells. At 4°C high-affinity binding was absent in stearate- and palmitate-supplemented cells, but was maintained in linoleate-supplemented cells. These studies suggest that the unsaturated fatty acid content of the diet may not significantly affect the initiation stage of benzo(a)pyrene carcinogenesis, but may instead affect promotion. One possible mechanism for this could involved changes in the lipid microenvironment of membrane receptors involved in tumor promotion.
1 This work was supported by NIH Training Grants AM07258 and 5T32GM07182 (M. S. M.) and National Cancer Institute Grant CA-21111 (M. S. M., A. M. J.).
2 Current address: Dept. of Dermatology, Columbia University, New York, NY 10032.
3 To whom requests for reprints should be addressed.
Received 8/ 5/86. Revised 1/21/87. Accepted 2/ 9/87.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |